UTHealth Houston researchers identified six protein signatures in about 273 children around age 8 that are linked to a higher risk of cardiovascular-kidney-metabolic disease in adulthood.

Comparisons with GLP-1 drug trials showed most high-risk proteins were reversible in adults taking GLP-1 therapies, suggesting the risk state is modifiable.

Using machine learning, scientists connected circulating protein patterns to disease-associated phenotypes and found similar signatures in 685 adults from the same community and in more than 28,000 UK Biobank adults, indicating a shared CKMD proteomic profile across ages.

The study is a multi-institution collaboration among UTHealth Houston, Vanderbilt, UNC Chapel Hill, and others, with publication DOI 10.1038/s42255-026-01589-7.

Brownsville-based Border Health Research Cohort is highlighted as a valuable resource for linking pediatric traits to adult disease and recognizing the community's essential role in the study.

Researchers note that current efforts to combat childhood obesity have had limited success, but proteomic signatures may enable early identification of at-risk children for targeted interventions.

Defining childhood biomarkers with prognostic and genetic links to adult CKMD outcomes is crucial for enabling early surveillance and preventive interventions that could alter disease trajectories.

Many participating children already showed phenotypes linked to cardiometabolic risk, including obesity, liver function issues, cholesterol, and insulin resistance, with some blood tests going beyond routine pediatric visits.

The study analyzed blood samples and physical measures from 273 children in Cameron County, Texas, finding that over one-third exhibited phenotypes connecting obesity, high blood pressure, prediabetic insulin resistance, and lipid profiles to elevated heart disease risk.

Researchers advocate for early intervention and precision medicine, suggesting childhood screening could identify those at elevated risk and enable earlier measures to reduce future cardiometabolic disease burden.

Proteomic signatures are presented as actionable targets for reversing disease risk in childhood and advancing precision prevention of CKMD.

Senior authors emphasize the potential impact of reversing protein signatures in childhood to lower future disease burden and push for improved pediatric screening and timely action when risk is found.